Effect of sucralfate in treatment of post operation anal fistula wound

A comparison between the effects of Topical ointment Sucralfate10% and topical placebo on Wound Healing & Postoperative pain in patients with prianal Fistula after surgery

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT2015041414483N5

Enrollment

Registered

2015-05-08

Start date

2014-11-22

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Perianal fistula. Anal fistula

Interventions

Intervention 1: The control group:taking pelacebo topical ointment vaselin twice daily for 6weeks. Intervention 2: The intervention group:taking Topical ointment sucralfat 10% twice daily for 6weeks

Treatment - Drugs

The control group:taking pelacebo topical ointment vaselin twice daily for 6weeks

The intervention group:taking Topical ointment sucralfat 10% twice daily for 6weeks

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Inclusion criteria:all the patients whose perianal fistula was operated(fistulotomy) Exclusion criteria:long term consumption of corticosteroid;poorly controlled diabetic patients ;the patient who suffering TB; crohn disease ;malignancy ;radiation therapy ;the patients whose are on chemotherapy and pased less than two weeks after chemotherapy.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Post op pain. Timepoint: 2,4,6weeks after intervention. Method of measurement: VAS.;Wound healing. Timepoint: 2,4,6weeks after intervention. Method of measurement: Mucosal coverage of wound.	—

Secondary

Measure	Time frame
Painful deffication. Timepoint: 2,4,6weeks after intervention. Method of measurement: VAS.;Discharge. Timepoint: 2,4,6 weeks after intervention. Method of measurement: Visual observation.;Itching. Timepoint: 2,4,6 weeks after intervention. Method of measurement: 5-D pruritis scale.;Post op coplication. Timepoint: 2,4,6 weeks after intervention. Method of measurement: Physical examination.;Side effect of medication. Timepoint: 2,4,6 weeks after intervention. Method of measurement: History.;Post op bleeding. Timepoint: 2,4,6weeks after intervention. Method of measurement: Physical examination.;Fecal incontinency. Timepoint: 2,4,6weeks after itervention. Method of measurement: History.;Gas incontinency. Timepoint: 2,4,6 weeks after intervention. Method of measurement: History.;Couret count. Timepoint: 2,4,6 weeks after intervention. Method of measurement: Count number.	—

Measure

Time frame

Painful deffication. Timepoint: 2,4,6weeks after intervention. Method of measurement: VAS.;Discharge. Timepoint: 2,4,6 weeks after intervention. Method of measurement: Visual observation.;Itching. Timepoint: 2,4,6 weeks after intervention. Method of measurement: 5-D pruritis scale.;Post op coplication. Timepoint: 2,4,6 weeks after intervention. Method of measurement: Physical examination.;Side effect of medication. Timepoint: 2,4,6 weeks after intervention. Method of measurement: History.;Post op bleeding. Timepoint: 2,4,6weeks after intervention. Method of measurement: Physical examination.;Fecal incontinency. Timepoint: 2,4,6weeks after itervention. Method of measurement: History.;Gas incontinency. Timepoint: 2,4,6 weeks after intervention. Method of measurement: History.;Couret count. Timepoint: 2,4,6 weeks after intervention. Method of measurement: Count number.

—

Countries

Iran (Islamic Republic of)

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026